Fewer than half of ob/gyns counsel pregnant patients on risk of congenital cytomegalovirus and on preventive measures.
Fewer than half of obstetricians and gynecologists counsel pregnant patients on the risk of congenital cytomegalovirus and on preventive measures they can take to minimize the chances of infection, according to a report published in the Jan. 25 issue of the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
B. Anderson, PhD, of the American College of Obstetricians and Gynecologists and colleagues surveyed 305 ob/gyns on their knowledge of cytomegalovirus prevention and on their communication to pregnant patients regarding cytomegalovirus.
Although 90% said they knew that the risk of cytomegalovirus infection during pregnancy could be reduced by handwashing, only 60% reported advising their pregnant patients to do so, and only 44% counseled their patients specifically on avoiding cytomegalovirus infection. Since 2003, nearly 27% of respondents had diagnosed cytomegalovirus infection in a pregnant patient.
Centers for Disease Control and Prevention (CDC). Knowledge and practices of obstetricians and gynecologists regarding cytomegalovirus infection during pregnancy-United States, 2007. MMWR Morb Mortal Wkly Rep. 2008;57:65-68.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More